| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.5 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |